Učitavanje...
A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses
There is an urgent need for monoclonal antibody (mAb) therapies that broadly protect against Ebola virus and other filoviruses. The conserved, essential interaction between the filovirus glycoprotein, GP, and its entry receptor Niemann-Pick C1 (NPC1) provides an attractive target for such mAbs but i...
Spremljeno u:
| Izdano u: | Science |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5647781/ https://ncbi.nlm.nih.gov/pubmed/27608667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aag3267 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|